glp 1 and addiction IUPHAR review – Glucagon-like peptide-1 (GLP-1) substance use disorders: An emerging pharmacotherapeutic target GLP-1 Drugs for Addiction: Hype
Description
Physiol Behav Elsevier Inc
Wonderful experience, helping lose my perimenopause weight gain
The negative effects seem minimal. Babak Firoozi, MD MNT also spoke with Seth Kipnis, MD, FACS, FASMBS, medical director of Bariatric and Robotic Surgery at Hackensack Meridian Jersey Shore University Medical Center in New Jersey, about this research
Front Cell Neurosci 2016
GLP-1 medications require refrigeration
GLP-1R agonists cannot be currently recommended as targeted approaches for MASH but should be administered for their indications (T2D, obesity)
